Bruker Corporation revenue by segment BRKR

Annual Quarterly

Bruker Corporation splits its revenue 2 ways in its filings. By operating segments, the largest line in Q2 of fiscal 2026, the quarter ended Jun 30, 2026 was Bsi Calid at $310.3 million, 37% of the total. By sales mix, the largest line in Q2 of fiscal 2026, the quarter ended Jun 30, 2026 was Product at $663.7 million, 79% of the total.

USD in millions. The percent under a figure is the change from the same quarter a year earlier.

Line	TTM Jun 30, 2026	Q2 FY2026 Jun 30, 2026	Q1 FY2026 Mar 31, 2026	Q4 FY2025 Dec 31, 2025	Q3 FY2025 Sep 30, 2025	Q2 FY2025 Jun 30, 2025	Q1 FY2025 Mar 31, 2025	Q4 FY2024 Dec 31, 2024	Q3 FY2024 Sep 30, 2024
Revenue	3,500	838	823	977	860	797	801	980	864
Operating segments
Bsi Calid	1,271 +9.0% share 36.3%	310 +8.6% share 37.0%	316 +12.9% share 38.4%	332 +3.4% share 33.9%	313 +11.9% share 36.3%	286 share 35.8%	280 share 35.0%	321 share 32.7%	279 share 32.3%
Bsi Nano	1,083 -2.8% share 30.9%	261 +3.6% share 31.2%	246 -4.1% share 29.9%	309 -2.9% share 31.6%	266 -7.2% share 31.0%	252 share 31.6%	257 share 32.0%	318 share 32.5%	287 share 33.2%
Bsi Biospin	869 -4.4% share 24.8%	196 +0.2% share 23.3%	198 -5.0% share 24.0%	267 -2.0% share 27.3%	209 -10.4% share 24.3%	195 share 24.5%	208 share 25.9%	272 share 27.8%	233 share 27.0%
Energy And Supercon Technologies	277 +8.9% share 7.9%	71 +10.9% share 8.5%	64 +11.8% share 7.7%	70 +1.8% share 7.1%	73 +11.9% share 8.4%	64 share 8.1%	57 share 7.1%	68 share 7.0%	65 share 7.5%
Sales mix
Product	2,798 +0.1% share 80.0%	664 +4.6% share 79.2%	646 +0.5% share 78.5%	797 -1.4% share 81.6%	691 -2.6% share 80.3%	635 share 79.6%	643 share 80.3%	809 share 82.5%	709 share 82.1%
Product And Service Other	701 +8.4% share 20.0%	175 +7.4% share 20.8%	177 +12.0% share 21.5%	180 +5.2% share 18.4%	169 +9.2% share 19.7%	163 share 20.4%	158 share 19.7%	171 share 17.5%	155 share 17.9%

How these figures are calculated

Quarterly columns are single-quarter amounts. When a 10-Q reports only a year-to-date total, as cash flow statements do, the quarter is that total minus the previous quarter's year-to-date total. The fourth quarter is the annual report's full year minus the first nine months. A column marked YTD is a year-to-date total, shown when the earlier report needed for the single quarter is missing. USD in millions. Each group is a separate split of total revenue, so the groups are not added together. Share of revenue is that line divided by total revenue. The first column adds the latest year-to-date segment amount to the last fiscal year and subtracts the year-ago year-to-date amount. More on our methodology.

Company profile

Industry: Laboratory Analytical Instruments (SIC 3826)
Listed as: BRKR (Nasdaq), BRKRP (Nasdaq)
Fiscal year ends: December 31
Incorporated in: DE
Headquarters: Billerica, MA
SEC filer status: Large accelerated filer
SEC CIK: 1109354
Former names: BRUKER BIOSCIENCES CORP (until Feb 27, 2008); BRUKER DALTONICS INC (until Jul 2, 2003)

Other Laboratory Analytical Instruments companies

All 25 Laboratory Analytical Instruments companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.